BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21892331)

  • 1. Observational study of topical imiquimod immunotherapy in the treatment of difficult lentigo maligna.
    Craythorne EE; Lawrence CM
    Clin Med Oncol; 2008; 2():551-4. PubMed ID: 21892331
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment.
    Tio DCKS; van Montfrans C; Ruijter CGH; Hoekzema R; Bekkenk MW
    Acta Derm Venereol; 2019 Sep; 99(10):884-888. PubMed ID: 31233181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical imiquimod for periocular lentigo maligna.
    Demirci H; Shields CL; Bianciotto CG; Shields JA
    Ophthalmology; 2010 Dec; 117(12):2424-9. PubMed ID: 20591492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences.
    Poveda-Montoyo I; Álvarez-Chinchilla P; Schneller-Pavelescu L; Hispán-Ocete P; Bañuls-Roca J
    Actas Dermosifiliogr; 2022 Apr; 113(4):T407-T412. PubMed ID: 35623739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences.
    Poveda-Montoyo I; Álvarez-Chinchilla P; Schneller-Pavelescu L; Hispán-Ocete P; Bañuls-Roca J
    Actas Dermosifiliogr; 2022 Apr; 113(4):407-412. PubMed ID: 35431054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature.
    Vaienti S; Calzari P; Nazzaro G
    Dermatol Ther (Heidelb); 2023 Oct; 13(10):2187-2215. PubMed ID: 37615838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical imiquimod immunotherapy in the management of lentigo maligna.
    Powell AM; Russell-Jones R; Barlow RJ
    Clin Exp Dermatol; 2004 Jan; 29(1):15-21. PubMed ID: 14723712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentigo Maligna on a Difficult Location of the Face Treated with 5% Imiquimod: A Case Report of 2-Year Follow-Up.
    Misiak-Galazka M; Czuwara J; Galazka A; Czaplicka A; Rudnicka L
    Dermatol Ther (Heidelb); 2022 Feb; 12(2):599-604. PubMed ID: 35083713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of lentigo maligna with topical imiquimod.
    Naylor MF; Crowson N; Kuwahara R; Teague K; Garcia C; Mackinnis C; Haque R; Odom C; Jankey C; Cornelison RL
    Br J Dermatol; 2003 Nov; 149 Suppl 66():66-70. PubMed ID: 14616356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelanotic lentigo maligna managed with topical imiquimod as immunotherapy.
    Powell AM; Russell-Jones R
    J Am Acad Dermatol; 2004 May; 50(5):792-6. PubMed ID: 15097969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of periocular lentigo maligna with topical 5% Imiquimod: a review.
    Neumann I; Patalay R; Kaushik M; Timlin H; Daniel C
    Eye (Lond); 2023 Feb; 37(3):408-414. PubMed ID: 35835989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryosurgery during topical imiquimod: a successful combination modality for lentigo maligna.
    Bassukas ID; Gamvroulia C; Zioga A; Nomikos K; Fotika C
    Int J Dermatol; 2008 May; 47(5):519-21. PubMed ID: 18412875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance.
    Mora AN; Karia PS; Nguyen BM
    J Am Acad Dermatol; 2015 Aug; 73(2):205-12. PubMed ID: 26088690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lentigo maligna treated with 5% imiquimod cream].
    Martín T; Ojeda A; Martínez S; Vera A
    Actas Dermosifiliogr; 2005 Dec; 96(10):700-2. PubMed ID: 16476324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Change in lentigo maligna score assessed by in vivo reflectance confocal microscopy after 1 month of imiquimod treatment for lentigo maligna management.
    Soenen A; Vourc'h M; Khammari A; Nguyen JM; Bossard C; Denis Musquer M; Vergier B; Dréno B
    J Am Acad Dermatol; 2022 May; 86(5):1042-1048. PubMed ID: 33785385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical Imiquimod for Management of Recurrent Lentigo Maligna Melanoma in Situ.
    Bartenjev MS; Isaković-Vidović S; Bartenjev I
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):34-37. PubMed ID: 32650849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocryosurgery as monotherapy for lentigo maligna or combined with surgical excision for lentigo maligna melanoma.
    Matas-Nadal C; Sòria X; García-de-la-Fuente MR; Huerva V; Ortega E; Vilardell F; Gatius S; Casanova JM; Martí RM
    J Dermatol; 2018 May; 45(5):564-570. PubMed ID: 29430695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Periocular lentigo maligna treated with imiquimod.
    O'Neill J; Ayers D; Kenealy J
    J Dermatolog Treat; 2011 Apr; 22(2):109-12. PubMed ID: 20666668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical Imiquimod Treatment of Lentigo Maligna.
    Ventura F; Rocha J; Fernandes JC; Pardal F; Brito C
    Case Rep Dermatol; 2009 Oct; 1(1):78-81. PubMed ID: 20652120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures.
    Tio D; van der Woude J; Prinsen CAC; Jansma EP; Hoekzema R; van Montfrans C
    J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):616-624. PubMed ID: 27987308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.